Impact of hepatic immunoreactivity of angiotensin-converting enzyme 2 on liver fibrosis due to non-alcoholic steatohepatitis

Cengiz, Mustafa; Ozenirler, Seren; Yilmaz, Guldal; Erkan, Gulbanu

doi:10.1016/j.clinre.2015.02.010

Impact of hepatic immunoreactivity of angiotensin-converting enzyme 2 on liver fibrosis due to non-alcoholic steatohepatitis

Atıf İçin Kopyala

Cengiz M., Ozenirler S., Yilmaz G., Erkan G.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, cilt.39, sa.6, ss.692-698, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 39 Sayı: 6
Basım Tarihi: 2015
Doi Numarası: 10.1016/j.clinre.2015.02.010
Dergi Adı: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.692-698
Gazi Üniversitesi Adresli: Evet

Özet

Background: We aimed to evaluate the hepatic immunoreactivity of angiotensin-converting enzyme 2 (ACE2) in non-alcoholic steatohepatitis (NASH) patients, elucidate its association with the clinicopathological characteristics and also determine its role in fibrosis progression.